Relapse in leprosy

Indian Journal of Dermatology, Venereology and Leprology

Volumn 75, Issue 2, 2009, Pages 126-135

  Kaimal, Sowmya ^a   Thappa, Devinder ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Leprosy; Reactivation; Reinfection; Relapse; Resistance

Indexed keywords

CLARITHROMYCIN; CLOFAZIMINE; DAPSONE; MINOCYCLINE; OFLOXACIN; PREDNISOLONE; RIFAMPICIN; LEPROSTATIC AGENT;

CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA NODOSUM LEPROSUM; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL PROCEDURES; LEPROMIN TEST; LEPROSY; MULTIBACILLARY LEPROSY; MYCOBACTERIUM LEPRAE; NONHUMAN; PAPULE; PATIENT MONITORING; PAUCIBACILLARY LEPROSY; REINFECTION; RELAPSE; REVIEW; SKIN DEFECT; SKIN NODULE; WORLD HEALTH ORGANIZATION; ANIMAL; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOLOGY; SECONDARY PREVENTION;

ANIMALS; HUMANS; LEPROSTATIC AGENTS; LEPROSY; MYCOBACTERIUM LEPRAE; SECONDARY PREVENTION;

EID: 63149143989     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.48656     Document Type: Review

References (18)

1. The Leprosy Unit, WHO. Risk of relapse in leprosy. Indian J Lepr 1995;67:13-26.
2. Becx-Bleumink M. Relapses among leprosy patients treated with multidrug therapy: Experience in the leprosy control programme of the All Africa Leprosy and Rehabilitation and Training Centre (ALERT) in Ethiopia; Practical difficulties with diagnosing relapses, operational procedures and criteria for diagnosing relapses. Int J Lepr 1992;60:421-35.
3. Boerrigter G, Ponnighaus JM, Fine PE, Wilson RJ. Four-year follow up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi. Int J Lepr 1991;59:255-61.
4. Pandian TD, Sithambaram M, Bharathi R, Ramu G. A study of relapse in non-lepromatous and intermediate groups of leprosy. Indian J Lepr 1985;57:149-58.
5. Ali MK, Thorat DM, Subramanian M, Parthasarathy G, Selvaraj U, Prabhakar V. A study on trend of relapse in leprosy and factors influencing relapse. Indian J Lepr 2005;77:105-15.
6. Shen J, Liu M, Zhang J, Su W, Ding G. Relapse in MB leprosy patients treated with 24 months of MDT in south west China: A short report. Lepr Rev 2006;77:219-24.
7. Gebre S, Saunderson P, Byass P. Relapses after fixed duration multiple drug therapy: The AMFES cohort. Lepr Rev 2000;71:325-31.
8. Katoch VM. Microbiological aspects of relapse in leprosy. Indian J Lepr 1995;67:85-98.
9. Ebenezer GJ, Daniel S, Norman G, Daniel E, Job CK. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy? Indian J Lepr 2004;76:199-206.
10. Sengupta U. Immunological aspects of relapse in leprosy. Indian J Lepr 1995;67:81-3.
11. Bührer-Sékula S, Cunha MG, Foss NT, Oskam L, Faber WR, Klatser PR. Dipstick assay to identify leprosy patients who have an increased risk of relapse. Trop Med Int Health 2001;6:317-23.
12. Wu Q, Yin Y, Zhang L, Chen X, Yu Y, Li Z, et al. A study on a possibility of predicting early relapse in leprosy using a ND-O-BSA based ELISA. Int J Lepr Other Mycobact Dis 2002;70:1-8.
13. Job CK. Histopathological features of relapsed leprosy. Indian J Lepr 1995;67:69-80.
14. Ramu G. Clinical features and diagnosis of relapses in leprosy. Indian J Lepr 1995;67:45-59.
15. Pfaltzgraff RE, Ramu G. Clinical leprosy. In: Hastings RC, Opromolla DV, editors. Leprosy. 2nd ed. Edinburgh: Churchill Livingstone; 1994. p. 237-87.
16. Desikan KV. Relapse, reactivation or reinfection. Indian J Lepr 1995;67:3-11.
17. Jacobson RR. Treatment of relapsed leprosy. Indian J Lepr 1995;67:99-102.
18. Jacobson RR. Treatment of leprosy. In: Hastings RC, Opromolla DVA, editors. Leprosy. 2nd ed. Edinburgh: Churchill Livingstone; 1994. p. 317-49.